The efficacy of two dosages of a continuous combined hormone replacement regimen
- 1 February 2002
- Vol. 41 (2) , 123-131
- https://doi.org/10.1016/s0378-5122(01)00276-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetatePublished by Wolters Kluwer Health ,1999
- Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapyPublished by Wolters Kluwer Health ,1999
- P-25. Favorable Changes in Lipid and Lipoproteins Associated with Continuous-Combined 1 mg 17-Estradiol and Low Doses of Norethindrone AcetateMenopause, 1998
- Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?Climacteric, 1998
- Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy?American Journal of Obstetrics and Gynecology, 1997
- Relationship of Bone Turnover to Bone Density and FracturesJournal of Bone and Mineral Research, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacyBone, 1996
- Low Doses of 17β-Estradiol and Norethisterone Acetate as Continuous Combined Replacement Therapy in Postmenopausal Women: Lipid Metabolic EffectsMenopause, 1996
- Estrogen replacement therapy. A survey of women's knowledge and attitudesArchives of internal medicine (1960), 1989